These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19898216)

  • 1. Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina.
    Podlekareva DN; Mocroft A; Post FA; Riekstina V; Miro JM; Furrer H; Bruyand M; Panteleev AM; Rakhmanova AG; Girardi E; Losso MH; Toibaro JJ; Caylá J; Miller RF; Obel N; Skrahina A; Chentsova N; Lundgren JD; Kirk O;
    AIDS; 2009 Nov; 23(18):2485-95. PubMed ID: 19898216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.
    TB:HIV Study writing Group
    AIDS; 2017 Jan; 31(3):375-384. PubMed ID: 28081036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study.
    Podlekareva DN; Efsen AM; Schultze A; Post FA; Skrahina AM; Panteleev A; Furrer H; Miller RF; Losso MH; Toibaro J; Miro JM; Vassilenko A; Girardi E; Bruyand M; Obel N; Lundgren JD; Mocroft A; Kirk O;
    Lancet HIV; 2016 Mar; 3(3):e120-31. PubMed ID: 26939735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care index score and risk of death following tuberculosis diagnosis in HIV-positive patients.
    Podlekareva DN; Grint D; Post FA; Mocroft A; Panteleev AM; Miller RF; Miro JM; Bruyand M; Furrer H; Riekstina V; Girardi E; Losso MH; Caylá JA; Malashenkov EA; Obel N; Skrahina AM; Lundgren JD; Kirk O;
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):198-206. PubMed ID: 23317955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe.
    Podlekareva DN; Panteleev AM; Grint D; Post FA; Miro JM; Bruyand M; Furrer H; Obel N; Girardi E; Vasilenko A; Losso MH; Arenas-Pinto A; Caylá J; Rakhmanova A; Zeltina I; Werlinrud AM; Lundgren JD; Mocroft A; Kirk O;
    Eur Respir J; 2014 Jan; 43(1):166-77. PubMed ID: 23766333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TB meningitis in HIV-positive patients in Europe and Argentina: clinical outcome and factors associated with mortality.
    Efsen AM; Panteleev AM; Grint D; Podlekareva DN; Vassilenko A; Rakhmanova A; Zeltina I; Losso MH; Miller RF; Girardi E; Caylá J; Post FA; Miro JM; Bruyand M; Furrer H; Obel N; Lundgren JD; Mocroft A; Kirk O;
    Biomed Res Int; 2013; 2013():373601. PubMed ID: 24699884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after tuberculosis for people with HIV in eastern Europe.
    Kraef C; Bentzon A; Roen A; Bolokadze N; Thompson M; Azina I; Tetradov S; Skrahina A; Karpov I; Mitsura V; Paduto D; Trofimova T; Borodulina E; Mocroft A; Kirk O; Podlekareva DN;
    AIDS; 2023 Nov; 37(13):1997-2006. PubMed ID: 37503671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major Challenges in Clinical Management of TB/HIV Coinfected Patients in Eastern Europe Compared with Western Europe and Latin America.
    Efsen AM; Schultze A; Post FA; Panteleev A; Furrer H; Miller RF; Losso MH; Toibaro J; Skrahin A; Miro JM; Caylà JA; Girardi E; Bruyand M; Obel N; Podlekareva DN; Lundgren JD; Mocroft A; Kirk O;
    PLoS One; 2015; 10(12):e0145380. PubMed ID: 26716686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month survival of critically ill patients with HIV-related disease and tuberculosis: a retrospective study.
    Pecego AC; Amancio RT; Ribeiro C; Mesquita EC; Medeiros DM; Cerbino J; Grinsztejn B; Bozza FA; Japiassu AM
    BMC Infect Dis; 2016 Jun; 16():270. PubMed ID: 27286652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-drug-resistant tuberculosis in HIV positive patients in Eastern Europe.
    Post FA; Grint D; Werlinrud AM; Panteleev A; Riekstina V; Malashenkov EA; Skrahina A; Duiculescu D; Podlekareva D; Karpov I; Bondarenko V; Chentsova N; Lundgren J; Mocroft A; Kirk O; Miro JM;
    J Infect; 2014 Mar; 68(3):259-63. PubMed ID: 24247067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors.
    Kruk A; Bannister W; Podlekareva DN; Chentsova NP; Rakhmanova AG; Horban A; Domingo P; Mocroft A; Lundgren JD; Kirk O;
    AIDS; 2011 Jul; 25(12):1505-13. PubMed ID: 21610489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis.
    Wejse C; Furtado A; Camara C; Lüneborg-Nielsen M; Sodemann M; Gerstoft J; Katzenstein TL
    Int J Infect Dis; 2013 Oct; 17(10):e907-12. PubMed ID: 23816410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-related tuberculosis: mortality risk in persons without vs. with culture-confirmed disease.
    Crabtree-Ramírez B; Jenkins C; Jayathilake K; Carriquiry G; Veloso V; Padgett D; Gotuzzo E; Cortes C; Mejia F; McGowan CC; Duda S; Shepherd BE; Sterling TR
    Int J Tuberc Lung Dis; 2019 Mar; 23(3):306-314. PubMed ID: 30871661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.
    Swaminathan S; Narendran G; Venkatesan P; Iliayas S; Santhanakrishnan R; Menon PA; Padmapriyadarsini C; Ramachandran R; Chinnaiyan P; Suhadev M; Sakthivel R; Narayanan PR
    Am J Respir Crit Care Med; 2010 Apr; 181(7):743-51. PubMed ID: 19965813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS.
    Williams BG; Dye C
    Science; 2003 Sep; 301(5639):1535-7. PubMed ID: 12920302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new health care index predicts short term mortality for TB and HIV co-infected people.
    Roen AO; Podlekareva D; Miller RF; Mocroft A; Panteleev A; Skrahina A; Miro JM; Cayla JA; Tetradov S; Derisova E; Furrer H; Losso MH; Vassilenko A; Girardi E; Lundgren JD; Post FA; Kirk O
    Int J Tuberc Lung Dis; 2020 Sep; 24(9):956-962. PubMed ID: 33156764
    [No Abstract]   [Full Text] [Related]  

  • 17. Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study.
    Maruza M; Albuquerque MF; Braga MC; Barbosa MT; Byington R; Coimbra I; Moura LV; Batista JD; Diniz GT; Miranda-Filho DB; Lacerda HR; Rodrigues LC; Ximenes RA
    Int J Tuberc Lung Dis; 2012 May; 16(5):618-24. PubMed ID: 22410415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major challenges in clinical management of TB/HIV co-infected patients in Eastern Europe compared with Western Europe and Latin America.
    Efsen AM; Schultze A; Post F; Panteleev A; Furrer H; Miller R; Skrahin A; Losso MH; Toibaro J; Girardi E; Miro J; Bruyand M; Obel N; Caylá J; Podlekareva D; Lundgren J; Mocroft A; Kirk O
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19505. PubMed ID: 25394014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of discontinuation of nevirapine due to toxicities in antiretroviral-naive and -experienced HIV-infected patients with high and low CD4+ T-cell counts.
    Mocroft A; Staszewski S; Weber R; Gatell J; Rockstroh J; Gasiorowski J; Panos G; Monforte Ad; Rakhmanova A; Phillips AN; Lundgren JD;
    Antivir Ther; 2007; 12(3):325-33. PubMed ID: 17591022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death.
    Kingkaew N; Sangtong B; Amnuaiphon W; Jongpaibulpatana J; Mankatittham W; Akksilp S; Sirinak C; Nateniyom S; Burapat C; Kittikraisak W; Monkongdee P; Varma JK
    Int J Infect Dis; 2009 Nov; 13(6):722-9. PubMed ID: 19196530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.